Recent Updates
Recently added Catalysts
RADX Positive Sentiment Score: 80/100

Radiopharm Theranostics Announces Positive Phase 2b Trial Resultsof RAD 101 for Diagnosis of Brain Metastases

Thursday, July 23, 2026 1 min read
Key Takeaway: Radiopharm Theranostics has announced positive results from its Phase 2b trial of RAD 101, which is aimed at diagnosing brain metastases. The trial indicates that RAD 101 may be effective in improving diagnostic accuracy for this condition. This development could lead to better treatment strategies for patients with brain metastases.

Market Sentiment Analysis

POSITIVE FACTORS

  • Positive results from Phase 2b trial of RAD 101.
  • Effective diagnosis of brain metastases demonstrated.
  • Potential for improved patient outcomes.

Full Press Release Details

• Announcements , Updates
• PDF
• July 23, 2026
Loading Viewer…

More Announcements & Updates

• Announcements
• October 20, 2022
• Announcements
• February 2, 2022
• RAD Articles
• September 30, 2024
• Announcements
• April 22, 2024

Radiopharm Theranostics Announces Positive Phase 2b Trial Resultsof RAD 101 for Diagnosis of Brain Metastases

Radiopharm Theranostics Doses First Patient in Phase 1/2a ClinicalStudy of BetaBart (RV-01)

Zacks SCR Analysts Share Their Best Small-Cap Research Ideas for 2026

Radiopharm Theranostics Provides Positive Clinical Updates Across Four Programs

CLINICAL UPDATE AND CAPITAL RAISING OCTOBER 20th, 2025

Radiopharm Theranostics Receives IND approval from US FDA to Initiate Phase I Therapeutic Clinical Study to target B7H3 with Betabart (RV-01)

• Radiopharm Theranostics Announces Positive Phase 2b Trial Resultsof RAD 101 for Diagnosis of Brain Metastases
• RAD Presentation July 2026
• Zacks Small-Cap Research 2026
• Radiopharm Theranostics Doses First Patient in Phase 1/2a ClinicalStudy of BetaBart (RV-01)
• Zacks SCR Analysts Share Their Best Small-Cap Research Ideas for 2026
• Zacks Small-Cap Research

Frequently Asked Questions

What were the results of the RAD 101 trial?

The Phase 2b trial of RAD 101 showed positive results for diagnosing brain metastases.

What is the significance of RAD 101?

RAD 101 may improve diagnostic accuracy for patients with brain metastases.

Who conducted the RAD 101 trial?

The trial was conducted by Radiopharm Theranostics.

What is the focus of RAD 101?

RAD 101 focuses on the diagnosis of brain metastases.

Tags: RADX Viatris Investor Conferences Healthcare Radiopharm Theranostics RAD 101 brain metastases Phase 2b trial clinical trial
Last updated: Jul 23, 2026